Quinoline compound for combined treatment on breast cancer
A breast cancer, compound technology, applied in the field of quinoline compounds or their pharmaceutically acceptable salts, can solve problems such as toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0144] The following is to further illustrate the present invention in conjunction with specific embodiments and experimental examples. However, these examples are only for illustrating the present invention and are not used to limit the scope of the present invention. For the experimental methods that do not indicate specific experimental conditions in the following examples, follow the conventional conditions.
[0145] In patients with pathologically confirmed recurrent or metastatic triple-negative breast cancer with measurable disease and disease progression after at least prior anthracycline and / or taxane therapy, co-administration of anlotinib Ni and capecitabine. The specific administration method is as follows:
[0146] Capecitabine tablets: 1000mg / m 2 , 2 times a day, within 30 minutes after a meal, take orally for 2 weeks and stop for 1 week, that is, 3 weeks (21 days) is a treatment cycle, until the disease progresses or the adverse reactions are intolerable;
...
PUM
![No PUM](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap